journal article·2018-10-31Open access

Anticandidal activity of bioinspired ZnO NPs: effect on growth, cell morphology and key virulence attributes of Candida species

Mohammad Jalal, Mohammad Azam Ansari, Syed Ghazanfar Ali, Haris M Khan, Suriya Rehman

Abstract

The pathogenicity of Candida species in human is dependent on a variety of virulence factor such as adhesion factors, germ tube and hyphal formation, secretion of hydrolytic phospholipases and proteinases and drug resistance biofilm. ZnO NPs have been synthesized by using leaf extract of Crinum latifolium and were characterized by UV-Vis spectrophotometer, FTIR, SEM, EDX and TEM. In this study for the first time, potent inhibitory effects of ZnO NPs on principal virulence factors of Candida albicans and non-albicans such as germ tube formation, secretion of hydrolytic phospholipases and proteinases and biofilm formation has been investigated. ZnO NPs remarkably reduced the germ tube formation of C. albicans at 1 (86.4%), 0.5 (75.0%), 0.25 (61.4%), 0.125 (34.1%) and 0.062 mg/ml (11.4%). ZnO NPs significantly lowered the phospholipase and proteinase secretion by 58.8 and 95.2% at 0.25 mg/ml, respectively. CSLM results showed that ZnO NPs suppressed biofilm formation up to 85% at 0.25 mg/ml. SEM and TEM micrograph showed that ZnO NPs penetrated inside the cell and causes extensive damaged in cell wall and cell membrane. Inhibition of Candida growth and various virulent factors by ZnO NPs provides an insight towards their therapeutic application for the treatment of Candida-associated infections.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antifungal resistance and susceptibility · Chemical synthesis and alkaloids · Medicinal Plants and Neuroprotection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Microbiology, Jawaharlal Nehru Medical College and Hospital, Aligarh Muslim University

Department of Epidemic Disease Research, Institutes of Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University

References (73)

Show source-provided references
1. 10.1128/JCM.00403-0710.1128/JCM.00403-07 ↗
2. 10.1111/j.1574-6976.2011.00278.x10.1111/j.1574-6976.2011.00278.x ↗
3. 10.1086/37874510.1086/378745 ↗
4. 10.1111/j.1439-0507.2005.01165.x10.1111/j.1439-0507.2005.01165.x ↗
5. 10.4161/viru.2291310.4161/viru.22913 ↗
6. 10.1016/S0966-842X(01)02094-710.1016/S0966-842X(01)02094-7 ↗
7. 10.1128/iai.56.8.1987-1993.198810.1128/iai.56.8.1987-1993.1988 ↗
8. 10.1128/CMR.13.1.12210.1128/CMR.13.1.122 ↗
9. Yang YL. Virulence factors of Candida species. J Microbiol Immunol Infect. 2003;36:223–238.
10. Hube B. Candida albicans secreted aspartyl-proteinases. Curr Top Med Mycol. 1996;1:55–69.
11. 10.1590/0037-8682-0045-201310.1590/0037-8682-0045-2013 ↗
12. 10.3201/eid0702.01022610.3201/eid0702.010226 ↗
13. 10.1111/j.1439-0507.2011.02149.x10.1111/j.1439-0507.2011.02149.x ↗
14. 10.1128/EC.2.5.1053-1060.200310.1128/EC.2.5.1053-1060.2003 ↗
15. 10.1016/j.tim.2004.05.00810.1016/j.tim.2004.05.008 ↗
16. 10.1111/j.1462-5822.2006.00761.x10.1111/j.1462-5822.2006.00761.x ↗
17. 10.1111/j.1469-0691.2006.01369.x10.1111/j.1469-0691.2006.01369.x ↗
18. Ghosal S, Singh SK. (Chemical constituents of Amaryllidaceae. Part 24. Crinafoline and crinafolidine, two anti-tumor alkaloids from Crinum latifolium. J Chem Res. 1986;1986 (Suppl):312–313.
19. Beckstrom-Sternberg SM, Duke JA, Wain KK. The Ethnobotany Database Genome Informatics Group, National Agricultural Library. Beltsville (MD): U.S. Department of Agriculture; 1994.
20. 10.1515/znc-2002-3-40710.1515/znc-2002-3-407 ↗
21. Solanki J, Dhiman A, Nanda A, et al. Pharmacognostic and preliminary phytochemical evaluation of the leaves of Crinum latifolium L. Int J Pharma Sci Res. 2011; 2:3219–3223.
22. 10.9734/BBJ/2015/1840610.9734/BBJ/2015/18406 ↗
23. 10.5897/JMPR2016.620410.5897/JMPR2016.6204 ↗
24. Khan PA, Malik A, Khan HS. Profile of candidiasis in HIV infected patients. Iran J Microbiol. 2012;4:204–209.
25. Clinical and Laboratory Standards Institute. Method for antifungal disk diffusion susceptibility testing of yeasts; Approved guideline. 2nd ed. Wayne: Clinical and Laboratory Standards Institute; 2009.
26. 10.1039/C6RA23365A10.1039/C6RA23365A ↗
27. 10.1136/jcp.15.6.56310.1136/jcp.15.6.563 ↗
28. 10.1080/0036217828538003110.1080/00362178285380031 ↗
29. 10.4103/0253-7613.17452310.4103/0253-7613.174523 ↗
30. 10.1080/0036217828538034110.1080/00362178285380341 ↗
31. 10.4103/0255-0857.14840210.4103/0255-0857.148402 ↗
32. 10.1016/j.etap.2015.01.01510.1016/j.etap.2015.01.015 ↗
33. 10.1186/1477-3155-11-3910.1186/1477-3155-11-39 ↗
34. 10.1016/j.jksus.2016.10.00210.1016/j.jksus.2016.10.002 ↗
35. 10.1016/j.jcis.2016.03.02110.1016/j.jcis.2016.03.021 ↗
36. 10.1007/s10854-017-7254-210.1007/s10854-017-7254-2 ↗
37. Solanki J, Dhiman A, Nanda A, et al. Pharmacognostic and preliminary phytochemical evaluation of the leaves of Crinum latifolium. IJPSR. 2011;2:3219–3223.
38. 10.1039/C5RA24858B10.1039/C5RA24858B ↗
39. Anjum S, Abbasi BH. Biomimetic synthesis of antimicrobial silver nanoparticles using in vitro-propagated plantlets of a medicinally important endangered species: Phlomis bracteosa. Int J Nanomedicine. 2016;22:1663–1675.
40. 10.1016/j.mssp.2014.12.05310.1016/j.mssp.2014.12.053 ↗
41. 10.1016/j.saa.2015.07.06710.1016/j.saa.2015.07.067 ↗
42. 10.1155/2016/620480410.1155/2016/6204804 ↗
43. 10.4103/ijmr.IJMR_1773_1410.4103/ijmr.IJMR_1773_14 ↗
44. 10.1016/j.archoralbio.2016.02.00410.1016/j.archoralbio.2016.02.004 ↗
45. 10.2174/1570162X11311999004210.2174/1570162X113119990042 ↗
46. 10.3109/13693786.2010.55142410.3109/13693786.2010.551424 ↗
47. 10.1099/jmm.0.036269-010.1099/jmm.0.036269-0 ↗
48. 10.1007/s00253-011-3733-110.1007/s00253-011-3733-1 ↗
49. 10.1016/j.reffit.2017.05.00110.1016/j.reffit.2017.05.001 ↗
50. 10.1016/j.micres.2010.03.00310.1016/j.micres.2010.03.003 ↗
51. 10.1016/j.pnsc.2012.11.01510.1016/j.pnsc.2012.11.015 ↗
52. 10.1016/j.saa.2013.04.07210.1016/j.saa.2013.04.072 ↗
53. 10.1007/s40089-014-0107-610.1007/s40089-014-0107-6 ↗
54. 10.17795/zjrms-217910.17795/zjrms-2179 ↗
55. 10.1038/srep2768910.1038/srep27689 ↗
56. 10.1088/0957-4484/22/10/10510110.1088/0957-4484/22/10/105101 ↗
57. 10.1111/j.1439-0507.2011.02079.x10.1111/j.1439-0507.2011.02079.x ↗
58. 10.4103/0974-777X.7728810.4103/0974-777X.77288 ↗
59. Salyers A, Witt D. Virulence factors that damage the host. In: Salyers A, Witt D, editors. Bacterial pathogenesis: a molecular approach. Washington (DC): ASM Press; 1994. p. 47–62.
60. 10.1111/j.1439-0507.2004.01057.x10.1111/j.1439-0507.2004.01057.x ↗
61. 10.1111/j.1462-5822.2004.00439.x10.1111/j.1462-5822.2004.00439.x ↗
62. 10.1080/21691401.2017.132868810.1080/21691401.2017.1328688 ↗
63. Hajjar Esmaeil FHE, Jebali A, Hekmatimoghaddam S. The inhibition of Candida albicans secreted aspartyl proteinase by triangular gold nanoparticles. Nanomed J. 2015;2:54–59.
64. 10.1007/BF0156981610.1007/BF01569816 ↗
65. 10.1111/jmi.1258010.1111/jmi.12580 ↗
66. 10.1128/CMR.17.2.255-267.200410.1128/CMR.17.2.255-267.2004 ↗
67. 10.1111/j.1472-765X.2012.03219.x10.1111/j.1472-765X.2012.03219.x ↗
68. 10.1186/s12951-015-0147-810.1186/s12951-015-0147-8 ↗
69. 10.1038/srep2666710.1038/srep26667 ↗
70. 10.1016/j.jab.2017.02.00310.1016/j.jab.2017.02.003 ↗
71. 10.1016/j.archoralbio.2016.09.00310.1016/j.archoralbio.2016.09.003 ↗
72. 10.1080/21691401.2017.128286810.1080/21691401.2017.1282868 ↗
73. 10.1088/2043-6262/4/3/03501510.1088/2043-6262/4/3/035015 ↗